Inventor · disambiguated record
Allan Jordan
Also filed as: JORDAN ALLAN · JORDAN ALLAN M · JORDAN ALLAN MICHAEL
23 granted patents·9 pending applications·64 citations·filing 1998–2024
94Inventor score
Files withCANCER RESEARCH TECH LTD18VERNALIS R&D LTD7VERNALIS CAMBRIDGE LTD2DUKE STREET BIO LTD1DYMOCK BRIAN WILLIAM1
Top patents by PatentIndex Score
32 records- 0192US11680068B2Compounds useful as RET inhibitorsCANCER RESEARCH TECH LTD·Filed 2022·Granted Jun 20, 2023·1 cites·14 claims
- 0290US11352361B2Compounds useful as RET inhibitorsCANCER RESEARCH TECH LTD·Filed 2018·Granted Jun 7, 2022·3 cites·22 claims
- 0389US10954241B2Heterocyclic compounds as ret kinase inhibitorsCANCER RESEARCH TECH LTD·Filed 2017·Granted Mar 23, 2021·3 cites·29 claims
- 0488US10844067B2Heterocyclic compounds as RET kinase inhibitorsCANCER RESEARCH TECH LTD·Filed 2017·Granted Nov 24, 2020·4 cites·27 claims
- 0587US11548896B2Heterocyclic compounds as RET kinase inhibitorsCANCER RESEARCH TECH LTD·Filed 2021·Granted Jan 10, 2023·1 cites·30 claims
- 0685US11661423B2Heterocyclic compounds as RET kinase inhibitorsCANCER RESEARCH TECH LTD·Filed 2020·Granted May 30, 2023·1 cites·24 claims
- 0785US2025236624A1Heterocyclic Compounds as RET Kinase InhibitorsCANCER RESEARCH TECH LTD·Filed 2024·Application pending·0 cites
- 0884US12129236B2PARG inhibitory compoundsCANCER RESEARCH TECH LTD·Filed 2021·Granted Oct 29, 2024·1 cites·14 claims
- 0984US10995073B2PARG inhibitory compoundsCANCER RESEARCH TECH LTD·Filed 2019·Granted May 4, 2021·3 cites·16 claims
- 1083US10508086B2PARG inhibitory compoundsCANCER RESEARCH TECH LTD·Filed 2015·Granted Dec 17, 2019·3 cites·12 claims
- 1182US2025223266A1Parg inhibitory compoundsCANCER RESEARCH TECH LTD·Filed 2024·Application pending·0 cites
- 1282US2025243202A1Compounds Useful as RET InhibitorsCANCER RESEARCH TECH LTD·Filed 2024·Application pending·0 cites
- 1381US2024132504A1Compounds Useful as RET InhibitorsCANCER RESEARCH TECH LTD·Filed 2023·Application pending·0 cites
- 1478US2023339954A1Heterocyclic Compounds as RET Kinase InhibitorsCANCER RESEARCH TECH LTD·Filed 2022·Application pending·0 cites
- 1576US8354415B2Thienopyrimidine compounds and compositionsVERNALIS R&D LTD·Filed 2008·Granted Jan 15, 2013·3 cites·26 claims
- 1676US2024116938A1Heterocyclic Compounds as RET Kinase InhibitorsCANCER RESEARCH TECH LTD·Filed 2023·Application pending·0 cites
- 1775US10654846B2Autotaxin inhibitory compoundsCANCER RESEARCH TECH LTD·Filed 2016·Granted May 19, 2020·2 cites·2 claims
- 1875US10556911B2Thienopyrimidine compoundsVERNALIS R&D LTD·Filed 2018·Granted Feb 11, 2020·1 cites·36 claims
- 1975US9920066B2Thienopyrimidine compoundsVERNALIS R&D LTD·Filed 2017·Granted Mar 20, 2018·1 cites·8 claims
- 2074US9120807B2Thienopyrimidine compoundsJORDAN ALLAN·Filed 2008·Granted Sep 1, 2015·3 cites·25 claims
- 2174US7875600B2Pyrimidine compounds as purine receptor antagonistVERNALIS R&D LTD·Filed 2005·Granted Jan 25, 2011·2 cites·4 claims
- 2274US7820658B2Substituted thieno[2,3-d]pyrimidines as HSP90 inhibitorsVERNALIS CAMBRIDGE LTD·Filed 2004·Granted Oct 26, 2010·9 cites·23 claims
- 2371US9610290B2Thienopyrimidine compoundsVERNALIS R&D LTD·Filed 2015·Granted Apr 4, 2017·1 cites·24 claims
- 2470US6225463B1Synthesis of new β-lactamsPHARMACHEMIE BV·Filed 1998·Granted May 1, 2001·17 cites·9 claims
- 2568US10975056B2Substituted pyridines as inhibitors of DNMT1GLAXOSMITHKLINE IP DEV LTD·Filed 2017·Granted Apr 13, 2021·1 cites·21 claims
- 2668US8642594B2Substituted thieno[2,3-d]pyrimidines as HSP90 inhibitorsDYMOCK BRIAN WILLIAM·Filed 2010·Granted Feb 4, 2014·3 cites·15 claims
- 2767US11028097B2Thienopyrimidine compoundsVERNALIS R&D LTD·Filed 2019·Granted Jun 8, 2021·0 cites·20 claims
- 2863US10239843B22,4-dioxo-quinazoline-6-sulfonamide derivatives as inhibitors of PARGCANCER RESEARCH TECH LTD·Filed 2015·Granted Mar 26, 2019·1 cites·18 claims
- 2954US11453666B2Autotaxin inhibitory compoundsCANCER RESEARCH TECH LTD·Filed 2020·Granted Sep 27, 2022·0 cites·20 claims
- 3051US2024217968A1Pharmaceutical compoundDUKE STREET BIO LTD·Filed 2022·Application pending·0 cites
- 3148US2010305143A1Pyrrolopyrimidine compoundsVERNALIS R&D LTD·Filed 2008·Application pending·0 cites
- 3243US2007275961A1Triazolo ' 1, 5-A ! Pyrimidines and Their Use in MedicineVERNALIS CAMBRIDGE LTD·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Allan Jordan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →